SC S 54
in committeeMedical Informed Consent
South Carolina · 2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did SC S 54 pass?
Not yet. SC S 54 is in committee and has not come to a final vote. Latest recorded action (2025-04-22): Scrivener's error corrected
What is SC S 54 about?
A BILL TO AMEND THE SOUTH CAROLINA CODE OF LAWS SO AS TO ENACT THE "MEDICAL INFORMED CONSENT ACT"; BY ADDING SECTION 16-17-780 SO AS TO PROVIDE THAT IT IS UNLAWFUL FOR ANY PERSON, CORPORATION, HIGHER LEARNING INSTITUTION, OR THE STATE TO IMPLEMENT A VACCINE MANDATE AND TO PROVIDE PENALTIES; BY ADDING SECTION 41-1-55 SO AS TO PROHIBIT EMPLOYERS FROM TAKING ADVERSE ACTION AGAINST INDIVIDUALS WHO DECLINE TO RECEIVE A VACCINE AND TO PROVIDE PENALTIES; BY AMENDING SECTION 40-43-86, RELATING TO FACILITY REQUIREMENTS FOR PHARMACIES AND PRESCRIPTION DRUG ORDERS, SO AS TO PROVIDE CONDITIONS UNDER WHICH A PHARMACIST MAY REFUSE TO FILL A PRESCRIPTION; BY AMENDING SECTION 44-1-100, RELATING TO ASSISTANCE FROM PEACE AND HEALTH OFFICERS, SO AS TO REMOVE THE PROVISION THAT THE PUBLIC SAFETY AUTHORITY MAY REQUEST ASSISTANCE FROM THE STATE NATIONAL GUARD IN ENFORCING QUARANTINE MEASURES; BY AMENDING SECTION 44-4-130, RELATING TO PUBLIC HEALTH DEFINITIONS, SO AS TO PROVIDE DEFINITIONS OF "GENE THERAPY" AND "VACCINE" AND TO MAKE CONFORMING CHANGES; BY AMENDING SECTION 44-4-510, RELATING TO PHYSICAL EXAMINATIONS AND ISOLATION OR QUARANTINE OF PERSONS REFUSING EXAMINATION, SO AS TO PROVIDE THAT THE DEPARTMENT MAY ISOLATE A SYMPTOMATIC PERSON OR PERSON WHO HAS BEEN EXPOSED TO THE CONTAGIOUS DISEASE FOR WHICH A PUBLIC HEALTH EMERGENCY HAS BEEN DECLARED; BY AMENDING SECTION 44-4-520, RELATING TO VACCINATIONS AND TREATMENT, SO AS TO PROVIDE THAT THE DEPARTMENT MUST MONITOR THE SAFETY AND EFFICACY OF VACCINES, TESTS, AND TREATMENTS; BY AMENDING SECTION 44-4-530, RELATING TO ISOLATION AND QUARANTINE OF INDIVIDUALS OR GROUPS, AS WELL AS PENALTIES FOR NONCOMPLIANCE, SO AS TO PROVIDE A TIME LIMIT OF TWENTY-ONE DAYS FOR A QUARANTINED ASYMPTOMATIC PERSON; BY AMENDING SECTION 44-4-540, RELATING TO ISOLATION AND QUARANTINE PROCEDURES, SO AS TO CHANGE PROCEDURES; AND BY AMENDING SECTION 44-4-570, RELATING TO EMERGENCY POWERS REGARDING LICENSING OF HEALTH PERSONNEL, SO AS TO REMOVE THE REQUIREMENT THAT STATE HEALTH CARE PROVIDERS ASSIST IN THE PERFORMANCE OF VACCINATIONS AS A CONDITION OF LICENSURE.
Who sponsors SC S 54?
Martin, Rice, Kimbrell and 5 others are the primary sponsors of SC S 54.
Description
A BILL TO AMEND THE SOUTH CAROLINA CODE OF LAWS SO AS TO ENACT THE "MEDICAL INFORMED CONSENT ACT"; BY ADDING SECTION 16-17-780 SO AS TO PROVIDE THAT IT IS UNLAWFUL FOR ANY PERSON, CORPORATION, HIGHER LEARNING INSTITUTION, OR THE STATE TO IMPLEMENT A VACCINE MANDATE AND TO PROVIDE PENALTIES; BY ADDING SECTION 41-1-55 SO AS TO PROHIBIT EMPLOYERS FROM TAKING ADVERSE ACTION AGAINST INDIVIDUALS WHO DECLINE TO RECEIVE A VACCINE AND TO PROVIDE PENALTIES; BY AMENDING SECTION 40-43-86, RELATING TO FACILITY REQUIREMENTS FOR PHARMACIES AND PRESCRIPTION DRUG ORDERS, SO AS TO PROVIDE CONDITIONS UNDER WHICH A PHARMACIST MAY REFUSE TO FILL A PRESCRIPTION; BY AMENDING SECTION 44-1-100, RELATING TO ASSISTANCE FROM PEACE AND HEALTH OFFICERS, SO AS TO REMOVE THE PROVISION THAT THE PUBLIC SAFETY AUTHORITY MAY REQUEST ASSISTANCE FROM THE STATE NATIONAL GUARD IN ENFORCING QUARANTINE MEASURES; BY AMENDING SECTION 44-4-130, RELATING TO PUBLIC HEALTH DEFINITIONS, SO AS TO PROVIDE DEFINITIONS OF "GENE THERAPY" AND "VACCINE" AND TO MAKE CONFORMING CHANGES; BY AMENDING SECTION 44-4-510, RELATING TO PHYSICAL EXAMINATIONS AND ISOLATION OR QUARANTINE OF PERSONS REFUSING EXAMINATION, SO AS TO PROVIDE THAT THE DEPARTMENT MAY ISOLATE A SYMPTOMATIC PERSON OR PERSON WHO HAS BEEN EXPOSED TO THE CONTAGIOUS DISEASE FOR WHICH A PUBLIC HEALTH EMERGENCY HAS BEEN DECLARED; BY AMENDING SECTION 44-4-520, RELATING TO VACCINATIONS AND TREATMENT, SO AS TO PROVIDE THAT THE DEPARTMENT MUST MONITOR THE SAFETY AND EFFICACY OF VACCINES, TESTS, AND TREATMENTS; BY AMENDING SECTION 44-4-530, RELATING TO ISOLATION AND QUARANTINE OF INDIVIDUALS OR GROUPS, AS WELL AS PENALTIES FOR NONCOMPLIANCE, SO AS TO PROVIDE A TIME LIMIT OF TWENTY-ONE DAYS FOR A QUARANTINED ASYMPTOMATIC PERSON; BY AMENDING SECTION 44-4-540, RELATING TO ISOLATION AND QUARANTINE PROCEDURES, SO AS TO CHANGE PROCEDURES; AND BY AMENDING SECTION 44-4-570, RELATING TO EMERGENCY POWERS REGARDING LICENSING OF HEALTH PERSONNEL, SO AS TO REMOVE THE REQUIREMENT THAT STATE HEALTH CARE PROVIDERS ASSIST IN THE PERFORMANCE OF VACCINATIONS AS A CONDITION OF LICENSURE.
- Introduced
- 2025-01-14
- Latest action
- 2025-04-22 — Scrivener's error corrected
- Bill type
- bill
- Last updated
- —
Sponsors
- Martinprimary
- Riceprimary
- Kimbrellprimary
- Leberprimary
- Kennedyprimary
- Nuttprimary
- Corbinprimary
- Garrettprimary
Committees
Not provided by source.
Action timeline
Newest first
2025-04-22
Scrivener's error corrected
2025-04-15
Committee report: Favorable with amendment Medical Affairs
committee-passage-favorable
2025-01-14
Referred to Committee on Medical Affairs
referral-committee
2025-01-14
Introduced and read first time
introduction,reading-1
2024-12-11
Referred to Committee on Medical Affairs
referral-committee
2024-12-11
Prefiled
filing
Versions
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:32:06.227230Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=SC&identifier=S 54. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.